27, August, 2025

Market Highlights


Get the latest Indian stock / share market highlights, BSE/NSE stock news, business research reports & details - updated daily by Money Times.


August 13, 2025

  • Daily Morning Report           Date: 13th August 2025
  • NIFTY OUTLOOK: 24487.40  FII -3398.80 cr  DII 3507.93 cr
  • As discussed yesterday, market behaviour was in line with expectations. Nifty opened by defending the 24530 support and rallied to our resistance of 24695 (high of 24702.6) but failed to sustain and slipped towards our support of 24475, making a low of 24465.65.
  • A bearish candle with an upper shadow indicates selling pressure at higher levels.
  • A decisive breakdown below 24432 may lead to a fall towards 24377–24321, with further downside risk to 24266 if selling intensifies.
  • On the upside, 24543–24600 may act as immediate resistance. A sustained breakout above these levels could push Nifty towards 24653–24710.
  • Bank Nifty OUTLOOK:
  • SPOT: 55043.70  PCR: 0.70  Max CE OI: 57000  Max PE OI: 57000
  • On 12th August 2025, Bank Nifty closed at 55043.70, down 467.05 points (-0.84%), with an intraday movement of 565.20 points. The index recorded a high of 55566.70 and a low of 55001.50.
  • Technical View:
  • Key support lies in the 54820–54780 zone, while the next resistance is seen near 55900. Intraday support is placed at 54890 and resistance at 55200.
  • Intraday Technical Strategy:
  • Go long above 55200 with a stop loss at 55150 and a target of 55350.
  • Go short below 54890 with a stop loss at 54940 and a target of 54732.
  • Indicator Watch:
  • RSI for Bank Nifty stands at 37.10; levels below 30 are considered oversold and above 70 overbought.
  • Bank nifty Day SMA Analysis:
  • Bank nifty is trading above 3 out of 8 SMA’s (100, 150, 200 Day).
  • Bank nifty is trading below 5 out of 8 SMA’s. (5, 10, 20, 30, 50 Day)
  • No active candlestick Pattern was identified in bank nifty.
  • Macros:
  • 1. Dollar index @ 97.94
  • 2. S&P 500 Vix @ 14.76 (-9.11)
  • 3. Brent Crude @ 66.14 (-0.74%)
  • 4. US 10 years bond yield @ 4.293
  • Note:
  • The latest employment report confirmed signs of fragility and reduced dynamism in the U.S. labor market. The July jobs data, which reportedly led President Donald Trump to fire the head of the Bureau of Labor Statistics over claims it was “rigged,” is being viewed by Federal Reserve officials as serious evidence of a slowing economy and as justification for the interest rate cuts Trump has been advocating.
  • Following the weak July report and sharp downward revisions to June and May figures, market bets now indicate around a 90% probability that the Fed will cut rates by 25 basis points at its September meeting. Analysts suggest that this CPI reading strongly supports such a move, and if the August jobs report (due on 5th September) mirrors July’s weakness, a 50-basis-point reduction cannot be ruled out.
  • For Indian markets, the 27th August deadline will be crucial, along with the outcome of the Russia–US meeting scheduled for Friday. Any positive developments from this meeting could potentially lead to a rollback of the proposed 25% tariff before the 27th. Market participants should remain cautious and closely monitor these developments.
  • _________________________________
  • Data watch
  • 1.Fiis net long 7.9 % (Highly oversold).
  • 2.Fiis sold 3398.80 cr in cash segment, Sold 1025.08 cr in index and 452.49 in stock fut
  • 3.Vix @ 12.03 ( +2.23%)
  • 4.Pcr @ 0.64 (weekly) , 0.95 (monthly)
  • Note:
  • FIIs net long position is @ 7.9 (highly over sold zone) , Vix is @ 12.03 (+2.23%) again I will not change my view lower fiis net long & Vix not getting elevated rapidly is indicating index will again attempt to cover some shorts.
  • As far as figures are concerned ant dips around 24377-24321 will be buying zone for upside movement upto 24543 or if nifty able to break above 24550 is taken out nifty will go up to 24600-24650 .
  • If lower Vix & Highly over over sold fiis net long & PCR position is any indication some shorts may get cover, follow Index review for the same .
  • We need to observe certain data, Fiis net long as well as Vix if that does not increase (+2.91%) and nay reduction in fiis net long will trigger short covering.
  • -----------------------------------------------------------------
  • Contributed by
  • Ashok bhandari : INH000019549
  • -------------------------------------xxxxxxx-------------------------------------------------------------------xxxxxxx---------------------------------
  • Morgan Stanley on JSPL
  • Maintain Equal-weight | TP ₹950
  • EBITDA 16% ahead of consensus, driven by better realizations & lower RM costs
  • Angul project commissioning in final stages; production to start in a month
  • @beatthestreet10
  • Jefferies on Dr Agarwal
  • Maintain Hold | TP ↑ ₹430 from ₹380
  • In-line Q1; decent print
  • Aggressive expansion plans in India
  • On track to meet FY26 guidance; valuations punchy
  • @beatthestreet10
  • Morgan Stanley on Nykaa
  • Maintain Overweight | TP ₹225
  • In-line margins; Beauty growth on track
  • Focus on penetration and premiumization
  • Fashion EBITDA break-even targeted in FY26
  • @beatthestreet10
  • Jefferies on Honasa Consumer
  • Maintain Buy | TP ₹400
  • Positive margin surprise despite modest 7% revenue growth (impacted by unseasonal rains)
  • Sequential improvement in EBITDA margin
  • New brands growing; Mamaearth yet to recover
  • @beatthestreet10
  • Macquarie on Hindalco
  • Maintain Outperform | TP ₹709
  • EBITDA miss due to lower aluminium price, partly offset by better copper EBITDA
  • Downstream focus; upstream expansion likely by FY28
  • Earnings risk from tariff-led demand and cost pressures
  • @beatthestreet10
  • Morgan Stanley on HAL
  • Maintain Equal-weight | TP ₹5092
  • Q1 beat with higher gross margin (68%) and lower provisions
  • PAT beat supported by higher other income
  • @beatthestreet10
  • Jefferies on Aavas Financiers
  • Maintain Buy | TP ↓ ₹2175 from ₹2280
  • Q1 profit miss; loan growth pickup key
  • Disbursement down 5% YoY due to recognition policy change; normalization expected in Q2
  • EPS growth expected at 18% CAGR
  • @beatthestreet10
  • Jefferies on Zydus Life
  • Maintain Buy | TP ₹1150
  • Strong Q1 beat on growth in US & international markets
  • Controlled opex led to margin beat
  • FY26 guidance maintained; sustainable growth expected
  • @beatthestreet10
  • Jefferies on Belrise
  • Maintain Buy | TP ↑ ₹160 from ₹135
  • Good Q1 growth
  • Expect 12% EBITDA and 18% EPS CAGR over FY25-28
  • Positive on rising 2W demand, premiumization, exports, and deleveraging
  • Attractive valuation with room for multiple expansion
  • @beatthestreet10
  • Investec on Suzlon
  • Maintain Buy | TP ₹70
  • Strong execution; order book at all-time high
  • Net cash positive with strong RoE/RoCE
  • Positioned for 49%/26% revenue/PAT CAGR over FY25-27
  • @beatthestreet10
  • Nuvama on Hindustan Aeronautics (HAL)
  • Maintain Buy | TP ₹6,000
  • • Strong start with robust growth pipeline
  • • Order book of ~₹1.84 trillion at end-Mar’25, 6.1x FY25 sales
  • • Pipeline over ₹4.6 trillion in next 7-8 years
  • • Revenue CAGR ~21% expected over FY25-28E
  • • Planned capex ₹15,000 Cr over 4-5 years with working capital build-up
  • • EPS CAGR projected at ~11%
  • @beatthestreet10
  • MOSL on Bharat Dynamics (BDL)
  • Upgraded to Buy | TP ₹1,900
  • • Valuations now reasonable
  • • Strong order book of ₹23,300 Cr; execution to ramp up in coming quarters
  • • Large prospect pipeline of ₹50,000 Cr driving future growth
  • • Estimates maintained; execution & margins expected to improve
  • • Revenue/EBITDA to grow at 35%/64% CAGR over FY25-28
  • • EBITDA margin forecast: 23.8% (FY26), 24.7% (FY27), 25.5% (FY28)
  • • Trades at 39x (FY27E) and 29x (FY28E) EPS
  • @beatthestreet10
  • MOSL on Bharat Dynamics (BDL)
  • MOSL upgrades Bharat Dynamics (BDL) to Buy from Neutral; TP ₹1,900
  • Valuations now seen as reasonable
  • Strong order book of ₹23,300cr; execution expected to ramp up in coming quarters
  • Large prospect pipeline of ₹50,000cr to drive future growth
  • Estimates maintained; expect execution & margins to improve ahead
  • Revenue/EBITDA projected to grow at 35%/64% CAGR over FY25-28
  • EBITDA margin forecast at 23.8% (FY26), 24.7% (FY27), 25.5% (FY28)
  • Stock trades at 39x (FY27E) and 29x (FY28E) EPS
  • @beatthestreet10
  • Trump on Tariffs & Goldman Sachs
  • • Tariffs have not caused inflation — says Trump (ET NOW)
  • • Accuses Goldman Sachs of refusing to give credit where due
  • • Claims consumers aren’t even paying these tariffs
  • • Says Goldman Sachs and CEO David Solomon are wrong about tariff impacts on markets
  • • Adds David Solomon “shouldn’t bother running a bank”
  • @beatthestreet10
  • Avendus on Hindalco
  • Avendus maintains Sell on Hindalco; raises TP to ₹615 from ₹600
  • Novelis margin outlook remains challenging
  • Current margins likely at peak; aluminium prices could correct 10-15%
  • Expect softening Chinese and global aluminium demand with limited supply to balance market over next 12 months
  • Values Novelis/India operations at 6x/5x FY27E EV/EBITDA
  • Sell rating maintained
  • @beatthestreet10
  • MOSL on Hindalco
  • MOSL maintains Buy on Hindalco; target price ₹790
  • Strong Indian business performance driving overall earnings
  • Novelis EBITDA expected to rebound in 2H
  • Robust domestic earnings to offset muted Novelis profitability in FY26
  • Bay Minette commissioning to cut import dependency and free US capacities for high-margin products
  • Stock trades at 5.3x EV/EBITDA and 1.2x P/B on FY27E
  • Estimates largely unchanged; Buy rating reiterated
  • @beatthestreet10
  • PI Industries Q1
  • Q1 performance broadly in line with plan; company expects acceleration in H2
  • Growth outlook remains positive
  • Multiple levers in motion to sustain long-term growth momentum
  • Targeting single-digit revenue growth for FY26 with sustained margins (maintained guidance)
  • @beatthestreet10
  • Citi on Apollo Hospitals
  • Maintain Buy | TP ₹8,260
  • Q1 ahead; margin expansion in HealthCo and Hospitals
  • Solid growth and margin expansion in HealthCo
  • Hospitals business witnessed margin expansion despite decline in Bangladesh patients
  • HealthCo turned PAT positive in Q1
  • @beatthestreet10
  • Citi on Paytm
  • Maintain Buy | TP ₹1,215
  • RBI grants Payment Aggregator license
  • Removes major pending regulatory restriction
  • Paytm can leverage scale and product development to be more competitive in the segment
  • @beatthestreet10
  • MOSL on Hindustan Aeronautics (HAL)
  • Maintain Buy | TP ₹5,800 (raised from ₹5,750)
  • Engine supplies from GE for Tejas Mk1A ramping up
  • Aircraft deliveries expected to accelerate in coming quarters
  • Growth catalysts: Tejas deliveries + finalization of orders for 97 Tejas Mk1A units
  • Revenue projected to grow at 24% CAGR over FY25-28
  • EBITDA margin forecast: 29.8% (FY26), 28.6% (FY27), 27.3% (FY28)
  • Annual capex planned: ₹4,000cr (FY26), ₹5,000cr (FY27), ₹6,000cr (FY28)
  • PAT expected to grow at 17% CAGR over FY25-28
  • RoE/ROCE seen at 22.2%/22.6% by FY28
  • @beatthestreet10
  • Nuvama on Bharat Dynamics (BDL)
  • Nuvama maintains Buy on Bharat Dynamics; TP ₹2,250
  • Projects ~51% revenue CAGR and 66% EPS CAGR over FY25-28E
  • Operating margin (OPM) expected at 23-23.5%, benefiting from easing of supply constraints in critical imports
  • Assigns 45x target P/E on FY27E EPS of ₹50.1
  • Supply chain disruptions from dependence on war nations now easing
  • Strong positioning to deliver robust growth momentum ahead
  • @beatthestreet10
  • Nuvama on Titagarh
  • Nuvama maintains Buy on Titagarh; TP revised to ₹1,142 from ₹1,292
  • Quarter impacted by wheelset availability issues, hampering wagon production
  • Management expects Indian Railways to issue a new wagon tender in Q4FY26E / early FY27E
  • Wheelset shortages and muted wagon tendering prompt FY26E/FY27E EPS cuts of 12%/14%
  • TP cut as valuation rolled forward to Q1FY28E at 35x EPS
  • @beatthestreet10
  • Goldiam International launches QIP with floor price of 346 per share
  • @beatthestreet10
  • *Goldiam Intl Big Move*
  • Raising ~₹250 Cr fresh funds to turbocharge ORIGEM – 6 COCO stores in Mumbai today, 25 new in FY26, 250+ by FY28.
  • Lab-grown diamond retail = high margins + explosive growth.
  • Hearing a big retail player could acquire majority stake– just like Titan’s CaratLane jackpot.
  • Massive re-rating potential – Available at just 17x PE, this could be the next big retail jewellery story.
  • @beatthestreet10
  • SpiceJet to induct 10 Boeing 737s by Oct 2025 for peak winter and early summer demand
  • @beatthestreet10
  • SYRMA SGS: Syrma SGS has raised around ₹1,000 crore through a QIP, issuing 1.43 crore equity shares to QIBs at ₹699 per share, about 5% below the floor price.
  • The funds will be used for growth and strategic purposes.
  • The company’s paid-up capital has increased from ₹178.16 crore to ₹192.46 crore.
  • @beatthestreet10
Panchkarma